| Upper respiratory tract infection | Infections and infestations | MedDRA (11.1) | Systematic Assessment | | - EG0008 affected70 at risk
- EG0016 affected62 at risk
- EG00239 affected130 at risk
|
| Urinary tract infection | Infections and infestations | MedDRA (11.1) | Systematic Assessment | | - EG0007 affected70 at risk
- EG0012 affected62 at risk
- EG00225 affected130 at risk
|
| Bronchitis | Infections and infestations | MedDRA (11.1) | Systematic Assessment | | - EG0003 affected70 at risk
- EG0012 affected62 at risk
- EG00223 affected130 at risk
|
| Sinusitis | Infections and infestations | MedDRA (11.1) | Systematic Assessment | | - EG0004 affected70 at risk
- EG0011 affected62 at risk
- EG00219 affected130 at risk
|
| Nasopharyngitis | Infections and infestations | MedDRA (11.1) | Systematic Assessment | | - EG0005 affected70 at risk
- EG0010 affected62 at risk
- EG00216 affected130 at risk
|
| Gastroenteritis | Infections and infestations | MedDRA (11.1) | Systematic Assessment | | - EG0001 affected70 at risk
- EG0012 affected62 at risk
- EG0029 affected130 at risk
|
| Pneumonia | Infections and infestations | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0027 affected130 at risk
|
| Cellulitis | Infections and infestations | MedDRA (11.1) | Systematic Assessment | | - EG0001 affected70 at risk
- EG0010 affected62 at risk
- EG0026 affected130 at risk
|
| Gastroenteritis viral | Infections and infestations | MedDRA (11.1) | Systematic Assessment | | - EG0001 affected70 at risk
- EG0010 affected62 at risk
- EG0026 affected130 at risk
|
| Lower respiratory tract infection | Infections and infestations | MedDRA (11.1) | Systematic Assessment | | - EG0002 affected70 at risk
- EG0010 affected62 at risk
- EG0026 affected130 at risk
|
| Oral herpes | Infections and infestations | MedDRA (11.1) | Systematic Assessment | | - EG0001 affected70 at risk
- EG0010 affected62 at risk
- EG0026 affected130 at risk
|
| Otitis media | Infections and infestations | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0025 affected130 at risk
|
| Influenza | Infections and infestations | MedDRA (11.1) | Systematic Assessment | | - EG0001 affected70 at risk
- EG0012 affected62 at risk
- EG0024 affected130 at risk
|
| Cystitis | Infections and infestations | MedDRA (11.1) | Systematic Assessment | | - EG0002 affected70 at risk
- EG0010 affected62 at risk
- EG0023 affected130 at risk
|
| Eye infection | Infections and infestations | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0023 affected130 at risk
|
| Laryngitis | Infections and infestations | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0023 affected130 at risk
|
| Localised infection | Infections and infestations | MedDRA (11.1) | Systematic Assessment | | - EG0001 affected70 at risk
- EG0011 affected62 at risk
- EG0023 affected130 at risk
|
| Paronychia | Infections and infestations | MedDRA (11.1) | Systematic Assessment | | - EG0001 affected70 at risk
- EG0010 affected62 at risk
- EG0023 affected130 at risk
|
| Ear infection | Infections and infestations | MedDRA (11.1) | Systematic Assessment | | - EG0001 affected70 at risk
- EG0010 affected62 at risk
- EG0022 affected130 at risk
|
| Folliculitis | Infections and infestations | MedDRA (11.1) | Systematic Assessment | | - EG0001 affected70 at risk
- EG0010 affected62 at risk
- EG0022 affected130 at risk
|
| Furuncle | Infections and infestations | MedDRA (11.1) | Systematic Assessment | | - EG0001 affected70 at risk
- EG0010 affected62 at risk
- EG0022 affected130 at risk
|
| Herpes zoster | Infections and infestations | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0022 affected130 at risk
|
| Infected bites | Infections and infestations | MedDRA (11.1) | Systematic Assessment | | - EG0001 affected70 at risk
- EG0010 affected62 at risk
- EG0022 affected130 at risk
|
| Labyrinthitis | Infections and infestations | MedDRA (11.1) | Systematic Assessment | | - EG0001 affected70 at risk
- EG0010 affected62 at risk
- EG0022 affected130 at risk
|
| Tinea pedis | Infections and infestations | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0011 affected62 at risk
- EG0022 affected130 at risk
|
| Tooth abscess | Infections and infestations | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0011 affected62 at risk
- EG0022 affected130 at risk
|
| Viral infection | Infections and infestations | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0011 affected62 at risk
- EG0022 affected130 at risk
|
| Alveolar osteitis | Infections and infestations | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Blister infected | Infections and infestations | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Bronchiectasis | Infections and infestations | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Burn infection | Infections and infestations | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Clostridial infection | Infections and infestations | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Clostridium difficile colitis | Infections and infestations | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Fungal infection | Infections and infestations | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0011 affected62 at risk
- EG0021 affected130 at risk
|
| Fungal skin infection | Infections and infestations | MedDRA (11.1) | Systematic Assessment | | - EG0001 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Gastrointestinal infection | Infections and infestations | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Gingival infection | Infections and infestations | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Helicobacter gastritis | Infections and infestations | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Helicobacter infection | Infections and infestations | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Hordeolum | Infections and infestations | MedDRA (11.1) | Systematic Assessment | | - EG0001 affected70 at risk
- EG0011 affected62 at risk
- EG0021 affected130 at risk
|
| Impetigo | Infections and infestations | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Infected cyst | Infections and infestations | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Kidney infection | Infections and infestations | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Nail infection | Infections and infestations | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Onychomycosis | Infections and infestations | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Oral candidiasis | Infections and infestations | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Osteomyelitis | Infections and infestations | MedDRA (11.1) | Systematic Assessment | | - EG0001 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Papilloma viral infection | Infections and infestations | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Pharyngitis | Infections and infestations | MedDRA (11.1) | Systematic Assessment | | - EG0001 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Postoperative wound infection | Infections and infestations | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Respiratory tract infection | Infections and infestations | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Rhinitis | Infections and infestations | MedDRA (11.1) | Systematic Assessment | | - EG0001 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Sinobronchitis | Infections and infestations | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Staphylococcal infection | Infections and infestations | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Tinea cruris | Infections and infestations | MedDRA (11.1) | Systematic Assessment | | - EG0001 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Tooth infection | Infections and infestations | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Vulvovaginal candidiasis | Infections and infestations | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Vulvovaginal mycotic infection | Infections and infestations | MedDRA (11.1) | Systematic Assessment | | - EG0001 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Wound infection | Infections and infestations | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Genital herpes | Infections and infestations | MedDRA (11.1) | Systematic Assessment | | - EG0001 affected70 at risk
- EG0010 affected62 at risk
- EG0020 affected130 at risk
|
| Rheumatoid arthritis | Musculoskeletal and connective tissue disorders | MedDRA (11.1) | Systematic Assessment | | - EG0004 affected70 at risk
- EG0016 affected62 at risk
- EG00216 affected130 at risk
|
| Back pain | Musculoskeletal and connective tissue disorders | MedDRA (11.1) | Systematic Assessment | | - EG0001 affected70 at risk
- EG0012 affected62 at risk
- EG00213 affected130 at risk
|
| Arthralgia | Musculoskeletal and connective tissue disorders | MedDRA (11.1) | Systematic Assessment | | - EG0001 affected70 at risk
- EG0010 affected62 at risk
- EG00211 affected130 at risk
|
| Bursitis | Musculoskeletal and connective tissue disorders | MedDRA (11.1) | Systematic Assessment | | - EG0002 affected70 at risk
- EG0010 affected62 at risk
- EG0029 affected130 at risk
|
| Muscle spasms | Musculoskeletal and connective tissue disorders | MedDRA (11.1) | Systematic Assessment | | - EG0001 affected70 at risk
- EG0011 affected62 at risk
- EG0028 affected130 at risk
|
| Intervertebral disc degeneration | Musculoskeletal and connective tissue disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0026 affected130 at risk
|
| Osteoarthritis | Musculoskeletal and connective tissue disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0025 affected130 at risk
|
| Osteopenia | Musculoskeletal and connective tissue disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0025 affected130 at risk
|
| Musculoskeletal chest pain | Musculoskeletal and connective tissue disorders | MedDRA (11.1) | Systematic Assessment | | - EG0001 affected70 at risk
- EG0011 affected62 at risk
- EG0024 affected130 at risk
|
| Rheumatoid nodule | Musculoskeletal and connective tissue disorders | MedDRA (11.1) | Systematic Assessment | | - EG0002 affected70 at risk
- EG0011 affected62 at risk
- EG0024 affected130 at risk
|
| Tendonitis | Musculoskeletal and connective tissue disorders | MedDRA (11.1) | Systematic Assessment | | - EG0003 affected70 at risk
- EG0011 affected62 at risk
- EG0024 affected130 at risk
|
| Musculoskeletal pain | Musculoskeletal and connective tissue disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0011 affected62 at risk
- EG0023 affected130 at risk
|
| Myalgia | Musculoskeletal and connective tissue disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0023 affected130 at risk
|
| Pain in extremity | Musculoskeletal and connective tissue disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0011 affected62 at risk
- EG0023 affected130 at risk
|
| Rotator cuff syndrome | Musculoskeletal and connective tissue disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0023 affected130 at risk
|
| Fibromyalgia | Musculoskeletal and connective tissue disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0011 affected62 at risk
- EG0022 affected130 at risk
|
| Foot deformity | Musculoskeletal and connective tissue disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0022 affected130 at risk
|
| Joint swelling | Musculoskeletal and connective tissue disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0022 affected130 at risk
|
| Periarthritis | Musculoskeletal and connective tissue disorders | MedDRA (11.1) | Systematic Assessment | | - EG0001 affected70 at risk
- EG0010 affected62 at risk
- EG0022 affected130 at risk
|
| Spinal osteoarthritis | Musculoskeletal and connective tissue disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0022 affected130 at risk
|
| Arthritis | Musculoskeletal and connective tissue disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Bunion | Musculoskeletal and connective tissue disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Costochondritis | Musculoskeletal and connective tissue disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Exostosis | Musculoskeletal and connective tissue disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Flank pain | Musculoskeletal and connective tissue disorders | MedDRA (11.1) | Systematic Assessment | | - EG0001 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Joint effusion | Musculoskeletal and connective tissue disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Ligament disorder | Musculoskeletal and connective tissue disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Muscle twitching | Musculoskeletal and connective tissue disorders | MedDRA (11.1) | Systematic Assessment | | - EG0001 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Musculoskeletal stiffness | Musculoskeletal and connective tissue disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Osteoporosis | Musculoskeletal and connective tissue disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Plantar fascitis | Musculoskeletal and connective tissue disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Tendon disorder | Musculoskeletal and connective tissue disorders | MedDRA (11.1) | Systematic Assessment | | - EG0001 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Tendon pain | Musculoskeletal and connective tissue disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Trigger finger | Musculoskeletal and connective tissue disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0011 affected62 at risk
- EG0021 affected130 at risk
|
| Vertebral foraminal stenosis | Musculoskeletal and connective tissue disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Intervertebral disc protrusion | Musculoskeletal and connective tissue disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0011 affected62 at risk
- EG0020 affected130 at risk
|
| Neck pain | Musculoskeletal and connective tissue disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0011 affected62 at risk
- EG0020 affected130 at risk
|
| Pain in jaw | Musculoskeletal and connective tissue disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0011 affected62 at risk
- EG0020 affected130 at risk
|
| Diarrhoea | Gastrointestinal disorders | MedDRA (11.1) | Systematic Assessment | | - EG0009 affected70 at risk
- EG0012 affected62 at risk
- EG00222 affected130 at risk
|
| Nausea | Gastrointestinal disorders | MedDRA (11.1) | Systematic Assessment | | - EG0001 affected70 at risk
- EG0012 affected62 at risk
- EG00212 affected130 at risk
|
| Vomiting | Gastrointestinal disorders | MedDRA (11.1) | Systematic Assessment | | - EG0004 affected70 at risk
- EG0011 affected62 at risk
- EG00210 affected130 at risk
|
| Gastritis | Gastrointestinal disorders | MedDRA (11.1) | Systematic Assessment | | - EG0005 affected70 at risk
- EG0010 affected62 at risk
- EG0028 affected130 at risk
|
| Abdominal pain | Gastrointestinal disorders | MedDRA (11.1) | Systematic Assessment | | - EG0002 affected70 at risk
- EG0012 affected62 at risk
- EG0027 affected130 at risk
|
| Abdominal pain upper | Gastrointestinal disorders | MedDRA (11.1) | Systematic Assessment | | - EG0001 affected70 at risk
- EG0010 affected62 at risk
- EG0027 affected130 at risk
|
| Gastrooesophageal reflux disease | Gastrointestinal disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0011 affected62 at risk
- EG0027 affected130 at risk
|
| Dyspepsia | Gastrointestinal disorders | MedDRA (11.1) | Systematic Assessment | | - EG0001 affected70 at risk
- EG0010 affected62 at risk
- EG0026 affected130 at risk
|
| Abdominal discomfort | Gastrointestinal disorders | MedDRA (11.1) | Systematic Assessment | | - EG0001 affected70 at risk
- EG0010 affected62 at risk
- EG0025 affected130 at risk
|
| Constipation | Gastrointestinal disorders | MedDRA (11.1) | Systematic Assessment | | - EG0001 affected70 at risk
- EG0010 affected62 at risk
- EG0025 affected130 at risk
|
| Mouth ulceration | Gastrointestinal disorders | MedDRA (11.1) | Systematic Assessment | | - EG0004 affected70 at risk
- EG0010 affected62 at risk
- EG0025 affected130 at risk
|
| Aphthous stomatitis | Gastrointestinal disorders | MedDRA (11.1) | Systematic Assessment | | - EG0001 affected70 at risk
- EG0010 affected62 at risk
- EG0023 affected130 at risk
|
| Dry mouth | Gastrointestinal disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0023 affected130 at risk
|
| Hiatus hernia | Gastrointestinal disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0011 affected62 at risk
- EG0023 affected130 at risk
|
| Cheilitis | Gastrointestinal disorders | MedDRA (11.1) | Systematic Assessment | | - EG0001 affected70 at risk
- EG0010 affected62 at risk
- EG0022 affected130 at risk
|
| Dental caries | Gastrointestinal disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0022 affected130 at risk
|
| Flatulence | Gastrointestinal disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0022 affected130 at risk
|
| Abdominal distension | Gastrointestinal disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Abdominal pain lower | Gastrointestinal disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Anal fistula | Gastrointestinal disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Barrett's Oesophagus | Gastrointestinal disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Duodenitis | Gastrointestinal disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Faeces discoloured | Gastrointestinal disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Gastrointestinal ulcer | Gastrointestinal disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Gingivitis | Gastrointestinal disorders | MedDRA (11.1) | Systematic Assessment | | - EG0001 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Haematochezia | Gastrointestinal disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Haemorrhoids | Gastrointestinal disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0011 affected62 at risk
- EG0021 affected130 at risk
|
| Irritable bowel syndrome | Gastrointestinal disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Lip swelling | Gastrointestinal disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Oesophageal irritation | Gastrointestinal disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Oesophagitis | Gastrointestinal disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Parotid gland enlargement | Gastrointestinal disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Peptic ulcer | Gastrointestinal disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Periodontitis | Gastrointestinal disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Rectal haemorrhage | Gastrointestinal disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Stomach discomfort | Gastrointestinal disorders | MedDRA (11.1) | Systematic Assessment | | - EG0001 affected70 at risk
- EG0010 affected62 at risk
- EG0020 affected130 at risk
|
| Oropharnygeal pain | Respiratory, thoracic and mediastinal disorders | MedDRA (11.1) | Systematic Assessment | | - EG0006 affected70 at risk
- EG0011 affected62 at risk
- EG00217 affected130 at risk
|
| Cough | Respiratory, thoracic and mediastinal disorders | MedDRA (11.1) | Systematic Assessment | | - EG0002 affected70 at risk
- EG0011 affected62 at risk
- EG00211 affected130 at risk
|
| Epistaxis | Respiratory, thoracic and mediastinal disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0012 affected62 at risk
- EG0024 affected130 at risk
|
| Asthma | Respiratory, thoracic and mediastinal disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0023 affected130 at risk
|
| Dyspnoea | Respiratory, thoracic and mediastinal disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0023 affected130 at risk
|
| Productive cough | Respiratory, thoracic and mediastinal disorders | MedDRA (11.1) | Systematic Assessment | | - EG0001 affected70 at risk
- EG0010 affected62 at risk
- EG0023 affected130 at risk
|
| Chronic obstructive pulmonary disease | Respiratory, thoracic and mediastinal disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0022 affected130 at risk
|
| Dysphonia | Respiratory, thoracic and mediastinal disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0022 affected130 at risk
|
| Nasal congestion | Respiratory, thoracic and mediastinal disorders | MedDRA (11.1) | Systematic Assessment | | - EG0001 affected70 at risk
- EG0010 affected62 at risk
- EG0022 affected130 at risk
|
| Respiratory tract congestion | Respiratory, thoracic and mediastinal disorders | MedDRA (11.1) | Systematic Assessment | | - EG0001 affected70 at risk
- EG0010 affected62 at risk
- EG0022 affected130 at risk
|
| Upper respiratory tract congestion | Respiratory, thoracic and mediastinal disorders | MedDRA (11.1) | Systematic Assessment | | - EG0002 affected70 at risk
- EG0010 affected62 at risk
- EG0022 affected130 at risk
|
| Nasal dryness | Respiratory, thoracic and mediastinal disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Nasal polyps | Respiratory, thoracic and mediastinal disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Pleural fibrosis | Respiratory, thoracic and mediastinal disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Pleurisy | Respiratory, thoracic and mediastinal disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Pulmonary fibrosis | Respiratory, thoracic and mediastinal disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Pulmonary oedema | Respiratory, thoracic and mediastinal disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Rhinitis allergic | Respiratory, thoracic and mediastinal disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0011 affected62 at risk
- EG0021 affected130 at risk
|
| Rhinorrhoea | Respiratory, thoracic and mediastinal disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Sinus congestion | Respiratory, thoracic and mediastinal disorders | MedDRA (11.1) | Systematic Assessment | | - EG0001 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Sneezing | Respiratory, thoracic and mediastinal disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Throat irritation | Respiratory, thoracic and mediastinal disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Upper airway obstruction | Respiratory, thoracic and mediastinal disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Upper-airway cough syndrome | Respiratory, thoracic and mediastinal disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Wheezing | Respiratory, thoracic and mediastinal disorders | MedDRA (11.1) | Systematic Assessment | | - EG0001 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Obstructive airways disorder | Respiratory, thoracic and mediastinal disorders | MedDRA (11.1) | Systematic Assessment | | - EG0001 affected70 at risk
- EG0010 affected62 at risk
- EG0020 affected130 at risk
|
| Rash | Skin and subcutaneous tissue disorders | MedDRA (11.1) | Systematic Assessment | | - EG0004 affected70 at risk
- EG0012 affected62 at risk
- EG00214 affected130 at risk
|
| Dermatitis contact | Skin and subcutaneous tissue disorders | MedDRA (11.1) | Systematic Assessment | | - EG0001 affected70 at risk
- EG0011 affected62 at risk
- EG0027 affected130 at risk
|
| Skin ulcer | Skin and subcutaneous tissue disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0024 affected130 at risk
|
| Increased tendency to bruise | Skin and subcutaneous tissue disorders | MedDRA (11.1) | Systematic Assessment | | - EG0001 affected70 at risk
- EG0011 affected62 at risk
- EG0023 affected130 at risk
|
| Pruritis | Skin and subcutaneous tissue disorders | MedDRA (11.1) | Systematic Assessment | | - EG0001 affected70 at risk
- EG0011 affected62 at risk
- EG0023 affected130 at risk
|
| Alopecia | Skin and subcutaneous tissue disorders | MedDRA (11.1) | Systematic Assessment | | - EG0002 affected70 at risk
- EG0010 affected62 at risk
- EG0022 affected130 at risk
|
| Dermal cyst | Skin and subcutaneous tissue disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0022 affected130 at risk
|
| Dermatitis | Skin and subcutaneous tissue disorders | MedDRA (11.1) | Systematic Assessment | | - EG0001 affected70 at risk
- EG0010 affected62 at risk
- EG0022 affected130 at risk
|
| Eczema | Skin and subcutaneous tissue disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0022 affected130 at risk
|
| Ingrowing nail | Skin and subcutaneous tissue disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0022 affected130 at risk
|
| Psoriasis | Skin and subcutaneous tissue disorders | MedDRA (11.1) | Systematic Assessment | | - EG0001 affected70 at risk
- EG0010 affected62 at risk
- EG0022 affected130 at risk
|
| Rash macular | Skin and subcutaneous tissue disorders | MedDRA (11.1) | Systematic Assessment | | - EG0001 affected70 at risk
- EG0010 affected62 at risk
- EG0022 affected130 at risk
|
| Blister | Skin and subcutaneous tissue disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Drug eruption | Skin and subcutaneous tissue disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Dry skin | Skin and subcutaneous tissue disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Eczema nummular | Skin and subcutaneous tissue disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Erythema | Skin and subcutaneous tissue disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0011 affected62 at risk
- EG0021 affected130 at risk
|
| Granuloma annulare | Skin and subcutaneous tissue disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Hyperkeratosis | Skin and subcutaneous tissue disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Night sweats | Skin and subcutaneous tissue disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Photosensitivity reaction | Skin and subcutaneous tissue disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Purpura | Skin and subcutaneous tissue disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Pustular psoriasis | Skin and subcutaneous tissue disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Rash erythematous | Skin and subcutaneous tissue disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Rash pruritic | Skin and subcutaneous tissue disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0011 affected62 at risk
- EG0021 affected130 at risk
|
| Rosacea | Skin and subcutaneous tissue disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Skin lesion | Skin and subcutaneous tissue disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0011 affected62 at risk
- EG0021 affected130 at risk
|
| Skin plaque | Skin and subcutaneous tissue disorders | MedDRA (11.1) | Systematic Assessment | | - EG0001 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Urticaria | Skin and subcutaneous tissue disorders | MedDRA (11.1) | Systematic Assessment | | - EG0001 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Seborrhoeic dermatitis | Skin and subcutaneous tissue disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0011 affected62 at risk
- EG0020 affected130 at risk
|
| Skin laceration | Injury, poisoning and procedural complications | MedDRA (11.1) | Systematic Assessment | | - EG0002 affected70 at risk
- EG0010 affected62 at risk
- EG0028 affected130 at risk
|
| Contusion | Injury, poisoning and procedural complications | MedDRA (11.1) | Systematic Assessment | | - EG0001 affected70 at risk
- EG0011 affected62 at risk
- EG0026 affected130 at risk
|
| Fall | Injury, poisoning and procedural complications | MedDRA (11.1) | Systematic Assessment | | - EG0001 affected70 at risk
- EG0012 affected62 at risk
- EG0026 affected130 at risk
|
| Foot fracture | Injury, poisoning and procedural complications | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0024 affected130 at risk
|
| Joint sprain | Injury, poisoning and procedural complications | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0011 affected62 at risk
- EG0023 affected130 at risk
|
| Meniscus lesion | Injury, poisoning and procedural complications | MedDRA (11.1) | Systematic Assessment | | - EG0001 affected70 at risk
- EG0010 affected62 at risk
- EG0023 affected130 at risk
|
| Arthropod bite | Injury, poisoning and procedural complications | MedDRA (11.1) | Systematic Assessment | | - EG0001 affected70 at risk
- EG0010 affected62 at risk
- EG0022 affected130 at risk
|
| Limb injury | Injury, poisoning and procedural complications | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0022 affected130 at risk
|
| Thermal burn | Injury, poisoning and procedural complications | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0022 affected130 at risk
|
| Anaemia postoperative | Injury, poisoning and procedural complications | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Animal scratch | Injury, poisoning and procedural complications | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Avulsion fracture | Injury, poisoning and procedural complications | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Excoriation | Injury, poisoning and procedural complications | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Hand fracture | Injury, poisoning and procedural complications | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Incision site haematoma | Injury, poisoning and procedural complications | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Joint injury | Injury, poisoning and procedural complications | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Laceration | Injury, poisoning and procedural complications | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Ligament sprain | Injury, poisoning and procedural complications | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Muscle injury | Injury, poisoning and procedural complications | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Muscle strain | Injury, poisoning and procedural complications | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0012 affected62 at risk
- EG0021 affected130 at risk
|
| Post procedural complication | Injury, poisoning and procedural complications | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Procedural headache | Injury, poisoning and procedural complications | MedDRA (11.1) | Systematic Assessment | | - EG0001 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Rib fracture | Injury, poisoning and procedural complications | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Spinal compression fracture | Injury, poisoning and procedural complications | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Wrist fracture | Injury, poisoning and procedural complications | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Fatigue | General disorders | MedDRA (11.1) | Systematic Assessment | | - EG0002 affected70 at risk
- EG0017 affected62 at risk
- EG00211 affected130 at risk
|
| Oedema peripheral | General disorders | MedDRA (11.1) | Systematic Assessment | | - EG0001 affected70 at risk
- EG0010 affected62 at risk
- EG0028 affected130 at risk
|
| Chest pain | General disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0024 affected130 at risk
|
| Pyrexia | General disorders | MedDRA (11.1) | Systematic Assessment | | - EG0001 affected70 at risk
- EG0010 affected62 at risk
- EG0024 affected130 at risk
|
| Influenza like illness | General disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0011 affected62 at risk
- EG0023 affected130 at risk
|
| Cyst | General disorders | MedDRA (11.1) | Systematic Assessment | | - EG0001 affected70 at risk
- EG0010 affected62 at risk
- EG0022 affected130 at risk
|
| Infusion related reaction | General disorders | MedDRA (11.1) | Systematic Assessment | | - EG0001 affected70 at risk
- EG0010 affected62 at risk
- EG0022 affected130 at risk
|
| Non-cardiac chest pain | General disorders | MedDRA (11.1) | Systematic Assessment | | - EG0002 affected70 at risk
- EG0010 affected62 at risk
- EG0022 affected130 at risk
|
| Chills | General disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Feeling hot | General disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Impaired healing | General disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Infusion site rash | General disorders | MedDRA (11.1) | Systematic Assessment | | - EG0001 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Metaplasia | General disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Oedema | General disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Pain | General disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Headache | Nervous system disorders | MedDRA (11.1) | Systematic Assessment | | - EG0004 affected70 at risk
- EG0010 affected62 at risk
- EG00215 affected130 at risk
|
| Dizziness | Nervous system disorders | MedDRA (11.1) | Systematic Assessment | | - EG0002 affected70 at risk
- EG0011 affected62 at risk
- EG0029 affected130 at risk
|
| Amnesia | Nervous system disorders | MedDRA (11.1) | Systematic Assessment | | - EG0001 affected70 at risk
- EG0010 affected62 at risk
- EG0022 affected130 at risk
|
| Migraine | Nervous system disorders | MedDRA (11.1) | Systematic Assessment | | - EG0001 affected70 at risk
- EG0010 affected62 at risk
- EG0022 affected130 at risk
|
| Neuropathy peripheral | Nervous system disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0022 affected130 at risk
|
| Aphasia | Nervous system disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Carotid artery disease | Nervous system disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Carotid artery stenosis | Nervous system disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Carpal tunnel syndrome | Nervous system disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Cauda equina syndrome | Nervous system disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Hypoaesthesia | Nervous system disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Lethargy | Nervous system disorders | MedDRA (11.1) | Systematic Assessment | | - EG0001 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Nerve compression | Nervous system disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Tarsal tunnel syndrome | Nervous system disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Tremor | Nervous system disorders | MedDRA (11.1) | Systematic Assessment | | - EG0001 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Lumbar radiculopathy | Nervous system disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0011 affected62 at risk
- EG0020 affected130 at risk
|
| Sinus headache | Nervous system disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0011 affected62 at risk
- EG0020 affected130 at risk
|
| Hepatic enzyme increased | Investigations | MedDRA (11.1) | Systematic Assessment | | - EG0001 affected70 at risk
- EG0011 affected62 at risk
- EG0026 affected130 at risk
|
| Alanine aminotransferase increased | Investigations | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0024 affected130 at risk
|
| Cardiac murmur | Investigations | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0023 affected130 at risk
|
| Transaminases increased | Investigations | MedDRA (11.1) | Systematic Assessment | | - EG0001 affected70 at risk
- EG0010 affected62 at risk
- EG0023 affected130 at risk
|
| Weight increased | Investigations | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0023 affected130 at risk
|
| Aspartate amniotransferase increased | Investigations | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Blood cholesterol increased | Investigations | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Blood thyroid stimulating hormone decreased | Investigations | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Blood triglycerides increased | Investigations | MedDRA (11.1) | Systematic Assessment | | - EG0001 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Haemoglobin decreased | Investigations | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Helicobacter test positive | Investigations | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Neutrophil count decreased | Investigations | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Serum ferritin decreased | Investigations | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| White blood cell count decreased | Investigations | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Band neutrophil count increased | Investigations | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0011 affected62 at risk
- EG0020 affected130 at risk
|
| Helicobacter pylori identification test positive | Investigations | MedDRA (11.1) | Systematic Assessment | | - EG0001 affected70 at risk
- EG0010 affected62 at risk
- EG0020 affected130 at risk
|
| Occult blood | Investigations | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0011 affected62 at risk
- EG0020 affected130 at risk
|
| Hypertension | Vascular disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0011 affected62 at risk
- EG00212 affected130 at risk
|
| Aortic aneurysm | Vascular disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0023 affected130 at risk
|
| Arteriosclerosis | Vascular disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0011 affected62 at risk
- EG0022 affected130 at risk
|
| Accelerated hypertension | Vascular disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Flushing | Vascular disorders | MedDRA (11.1) | Systematic Assessment | | - EG0001 affected70 at risk
- EG0011 affected62 at risk
- EG0021 affected130 at risk
|
| Hot flush | Vascular disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Hypotension | Vascular disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Peripheral artery aneurysm | Vascular disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Peripheral vascular disorder | Vascular disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Iliac artery stenosis | Vascular disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0011 affected62 at risk
- EG0020 affected130 at risk
|
| Phlebitis | Vascular disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0011 affected62 at risk
- EG0020 affected130 at risk
|
| Cataract | Eye disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0023 affected130 at risk
|
| Dry eye | Eye disorders | MedDRA (11.1) | Systematic Assessment | | - EG0001 affected70 at risk
- EG0010 affected62 at risk
- EG0023 affected130 at risk
|
| Ocular hyperaemia | Eye disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0022 affected130 at risk
|
| Asthenopia | Eye disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Conjunctival haemorrhage | Eye disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Conjunctivitis | Eye disorders | MedDRA (11.1) | Systematic Assessment | | - EG0001 affected70 at risk
- EG0011 affected62 at risk
- EG0021 affected130 at risk
|
| Conjunctivitis allergic | Eye disorders | MedDRA (11.1) | Systematic Assessment | | - EG0001 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Eye irritation | Eye disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0011 affected62 at risk
- EG0021 affected130 at risk
|
| Eye swelling | Eye disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Eyelid cyst | Eye disorders | MedDRA (11.1) | Systematic Assessment | | - EG0001 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Glaucoma | Eye disorders | MedDRA (11.1) | Systematic Assessment | | - EG0001 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Macular oedema | Eye disorders | MedDRA (11.1) | Systematic Assessment | | - EG0001 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Posterior capsule opacification | Eye disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Retinal tear | Eye disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Ulcerative keratitis | Eye disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Visual impairment | Eye disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Vitreous floaters | Eye disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Myodesopsia | Eye disorders | MedDRA (11.1) | Systematic Assessment | | - EG0001 affected70 at risk
- EG0010 affected62 at risk
- EG0020 affected130 at risk
|
| Insomnia | Psychiatric disorders | MedDRA (11.1) | Systematic Assessment | | - EG0001 affected70 at risk
- EG0010 affected62 at risk
- EG0029 affected130 at risk
|
| Depression | Psychiatric disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0014 affected62 at risk
- EG0025 affected130 at risk
|
| Anxiety | Psychiatric disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0011 affected62 at risk
- EG0022 affected130 at risk
|
| Confusional state | Psychiatric disorders | MedDRA (11.1) | Systematic Assessment | | - EG0001 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Libido increased | Psychiatric disorders | MedDRA (11.1) | Systematic Assessment | | - EG0001 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Restlessness | Psychiatric disorders | MedDRA (11.1) | Systematic Assessment | | - EG0001 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Dyslipidaemia | Metabolism and nutrition disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0025 affected130 at risk
|
| Hypercholesterolaemia | Metabolism and nutrition disorders | MedDRA (11.1) | Systematic Assessment | | - EG0001 affected70 at risk
- EG0010 affected62 at risk
- EG0024 affected130 at risk
|
| Hyperlipidaemia | Metabolism and nutrition disorders | MedDRA (11.1) | Systematic Assessment | | - EG0001 affected70 at risk
- EG0011 affected62 at risk
- EG0023 affected130 at risk
|
| Decreased appetite | Metabolism and nutrition disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0022 affected130 at risk
|
| Vitamin D deficiency | Metabolism and nutrition disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0022 affected130 at risk
|
| Hyperglycaemia | Metabolism and nutrition disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Hyperuricaemia | Metabolism and nutrition disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Hypokalaemia | Metabolism and nutrition disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0011 affected62 at risk
- EG0020 affected130 at risk
|
| Leukopenia | Blood and lymphatic system disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0026 affected130 at risk
|
| Anaemia | Blood and lymphatic system disorders | MedDRA (11.1) | Systematic Assessment | | - EG0001 affected70 at risk
- EG0010 affected62 at risk
- EG0023 affected130 at risk
|
| Neutropenia | Blood and lymphatic system disorders | MedDRA (11.1) | Systematic Assessment | | - EG0001 affected70 at risk
- EG0010 affected62 at risk
- EG0023 affected130 at risk
|
| Lymphadenopathy | Blood and lymphatic system disorders | MedDRA (11.1) | Systematic Assessment | | - EG0001 affected70 at risk
- EG0010 affected62 at risk
- EG0022 affected130 at risk
|
| Thrombocytopenia | Blood and lymphatic system disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0022 affected130 at risk
|
| Lymph node calcification | Blood and lymphatic system disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Splenic lesion | Blood and lymphatic system disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Splenomegaly | Blood and lymphatic system disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Prostatitis | Reproductive system and breast disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0022 affected130 at risk
|
| Benign prostatic hyperplasia | Reproductive system and breast disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Breast calcifications | Reproductive system and breast disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Breast cyst | Reproductive system and breast disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Breast tenderness | Reproductive system and breast disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Genital ulceration | Reproductive system and breast disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Menstrual disorder | Reproductive system and breast disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Pelvic pain | Reproductive system and breast disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Polymenorrhoea | Respiratory, thoracic and mediastinal disorders | MedDRA (11.1) | Systematic Assessment | | - EG0001 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Uterine synechiae | Respiratory, thoracic and mediastinal disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Menopausal symptoms | Reproductive system and breast disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0011 affected62 at risk
- EG0020 affected130 at risk
|
| Palpitations | Cardiac disorders | MedDRA (11.1) | Systematic Assessment | | - EG0003 affected70 at risk
- EG0010 affected62 at risk
- EG0024 affected130 at risk
|
| Coronary artery disease | Cardiac disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0022 affected130 at risk
|
| Supraventricular extrasystoles | Cardiac disorders | MedDRA (11.1) | Systematic Assessment | | - EG0001 affected70 at risk
- EG0010 affected62 at risk
- EG0022 affected130 at risk
|
| Atrial fibrillation | Cardiac disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Pericardial effusion | Cardiac disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Nephrolithiasis | Renal and urinary disorders | MedDRA (11.1) | Systematic Assessment | | - EG0001 affected70 at risk
- EG0011 affected62 at risk
- EG0023 affected130 at risk
|
| Dysuria | Renal and urinary disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Haematuria | Renal and urinary disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Pollakiuria | Renal and urinary disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Renal artery stenosis | Renal and urinary disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0011 affected62 at risk
- EG0021 affected130 at risk
|
| Renal colic | Renal and urinary disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Renal cyst | Renal and urinary disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Vertigo | Ear and labyrinth disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0011 affected62 at risk
- EG0022 affected130 at risk
|
| Ear congestion | Ear and labyrinth disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Ear pain | Ear and labyrinth disorders | MedDRA (11.1) | Systematic Assessment | | - EG0002 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Middle ear inflammation | Ear and labyrinth disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Tinnitus | Ear and labyrinth disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Cataract operation | Surgical and medical procedures | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Hip arthroplasty | Surgical and medical procedures | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Mole excision | Surgical and medical procedures | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Retinal operation | Surgical and medical procedures | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Rhinoplasty | Surgical and medical procedures | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Tooth extraction | Surgical and medical procedures | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Hepatic steatosis | Hepatobiliary disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0022 affected130 at risk
|
| Cholelithiasis | Hepatobiliary disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Hepatic lesion | Hepatobiliary disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Hyperbilirubinaemia | Hepatobiliary disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Bile duct stone | Hepatobiliary disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0011 affected62 at risk
- EG0020 affected130 at risk
|
| Seasonal allergy | Immune system disorders | MedDRA (11.1) | Systematic Assessment | | - EG0001 affected70 at risk
- EG0011 affected62 at risk
- EG0025 affected130 at risk
|
| Melanocytic naevus | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Skin papilloma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Squamous cell carcinoma of skin | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Lung neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0011 affected62 at risk
- EG0020 affected130 at risk
|
| Hypothyroidism | Endocrine disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0022 affected130 at risk
|
| Spinal column stenosis | Musculoskeletal and connective tissue disorders | MedDRA (11.1) | Systematic Assessment | | - EG0000 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|
| Blood pressure increased | Investigations | MedDRA (11.1) | Systematic Assessment | | - EG0001 affected70 at risk
- EG0010 affected62 at risk
- EG0021 affected130 at risk
|